Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Social Cognition Is Abnormal in Cervical Dystonia but Not Blepharospasm
Movement Disorders
P16 - Poster Session 16 (5:30 PM-6:30 PM)
3-014
To determine if deficits in social cognition exist in two types of isolated adult-onset focal dystonia
Dystonia, originally considered a pure motor disorder, is now recognized to have non-motor symptoms including psychiatric comorbidities, pain, and disturbed sleep. Cognitive dysfunction is a less established non-motor symptom. Investigations of social cognition in patients with cervical dystonia (CD) are limited, and not reported in other forms of focal dystonia such as blepharospasm (BSP). Deficits in SC make independent functioning (e.g. social awareness, public safety) challenging.

We performed a cross-sectional study evaluating SC in CD, BSP, and healthy controls (HC), using the Social Norms Questionnaire (SNQ22). Participants were excluded for cognitive impairment (Montreal Cognitive Assessment <26) and clinically significant depression or anxiety (Hospital Anxiety and Depression Scale scores >11). Statistical analysis was performed using an ANOVA model followed by pairwise comparisons, corrected for age, sex, education, and income.

Sixty patients were included: 26 CD, 18 BSP, and 16 HC. There was no significant difference in age, sex, education, or income between groups. SC was significantly different across groups (F=3.84, p=0.03). CD had lower SC compared to HC (p=0.02) and BSP (p=0.03). SC did not differ between BSP and HC (p=0.58). Depressive symptoms were also significantly different across groups (F=4.43, p=0.02).  Both CD and BSP had greater depressive symptoms than HC (CD: p=0.01; BSP: 0.04), while depressive symptoms did not differ between CD and BSP (p=0.74). 

CD is associated with deficits in SC, while BSP is not. Both BSP and CD, however, had greater depressive symptoms than controls, suggesting that depressive symptoms do not explain the SC deficits in CD. Our findings support that CD has a non-motor phenotype distinct from BSP, possibly due to a different underlying pathophysiology. Clinically, it is important to screen CD for SC deficits as they can be functionally limiting.

Authors/Disclosures
Jeanne Feuerstein, MD (University of Colorado School of Medicine)
PRESENTER
Dr. Feuerstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceutical. The institution of Dr. Feuerstein has received research support from Mowry Fund Grant. The institution of Dr. Feuerstein has received research support from Davis Phinney. Dr. Feuerstein has received research support from MJFF - Write Now Initiative. Dr. Feuerstein has received personal compensation in the range of $500-$4,999 for serving as a Parkinson's Expert for Legal Case with Keating Wagner Palidori. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Attending Neurologist with VAMC. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Assistant Professor of Neurology with University of Colorado.
Samantha K. Holden, MD, MS, FÂé¶¹´«Ã½Ó³»­ (University of Colorado School of Medicine) The institution of Dr. Holden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics.
Stefan Sillau Stefan Sillau has nothing to disclose.
Brian Berman, MD, MS, FÂé¶¹´«Ã½Ó³»­ (Virginia Commonwealth University) The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health. The institution of Dr. Berman has received research support from Neurocrine Biosciences. The institution of Dr. Berman has received research support from Benign Essential Blepharospasm Research Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.